DHS Confirms Additional Cases of Measles in Oconto County, Indicating Community Spread
DHS Confirms Additional Cases of Measles in Oconto County, Indicating Community Spread The Wisconsin Department of Health Services (DHS) and Oconto C…
Month: August 2025
Possible Measles Exposures in Wisconsin from Out-of-State Traveler
Possible Measles Exposures in Wisconsin from Out-of-State Traveler The Wisconsin Department of Health Services (DHS), in coordination with the St. Cro…
It’s Almost Flu Season. Should You Still Get a Shot, and Will Insurance Cover It?
For parents of school-aged children, the fall to-do list can seem ever-growing. Buy school supplies. Fill out endless school forms. Block off parent-teacher nights. Do…
Health Care Groups Aim To Counter Growing ‘National Scandal’ of Elder Homelessness
BRISTOL, R.I. — At age 82, Roberta Rabinovitz realized she had no place to go. A widow, she had lost both her daughters to cancer,…
Public Notification: Green Lumber contains hidden drug ingredient
[9-19-2019] The Food and Drug Administration is advising consumers not to purchase or use Green Lumber, a product promoted and sold for male sexual en…
BK251199 – NLF system® kit 2 (EUROMI)
The NLF SYSTEM® kit is indicated for removing tissues and/or liquids from the body following an infiltration of tumescent solutions, during surgical …
NASA’s PREFIRE CubeSat Mission Extended
NASA’s PREFIRE (Polar Radiant Energy in the Far-InfraRed Experiment) mission has been extended through September 2026 and is broadening its focus from Earth’s poles to…
Giant Radar Antenna Reflector on NASA-ISRO Satellite in Full ‘Bloom’
Spanning 39 feet (12 meters), the drum-shaped antenna reflector on the NISAR (NASA-ISRO Synthetic Aperture Radar) satellite mission from NASA and the Indian Space Research…
Breaking Down Why Medicare Part D Premiums Are Likely To Go Up
Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when…
FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis
FDA approved Papzimeos, the first-of-its-kind non-replicating adenoviral vector-based immunotherapy for use in adults with recurrent respiratory papil…